top of page

Marijuana Legalization Linked To Decreased Use Of Alcohol, Nicotine And Opioids, New Study Finds

  • Writer: Bob Marley
    Bob Marley
  • May 17, 2022
  • 2 min read

Marijuana legalization is associated with decreased use of alcohol, nicotine and non-prescription opioids among young adults, according to a new study.

Researchers at the University of Washington analyzed data on substance use trends from 2014 to 2019, finding that people aged 21-25 were less likely to consume the arguably more dangerous drugs post-legalization in the state.

The study, published in the Journal of Adolescent Health last week, looked at “six annual waves of cross-sectional survey data,” analyzing data from 12,694 adults.

“Contrary to concerns about spillover effects, implementation of legalized nonmedical cannabis coincided with decreases in alcohol and cigarette use and pain reliever misuse,” the study abstract said.

“The weakening association of cannabis use with the use of other substances among individuals ages 21–25 requires further research but may suggest increased importance of cannabis-specific prevention and treatment efforts,” it continued.

However, the study found that rates of past-month e-cigarette use did increase among that age group after 2016.

“Real-world data from legalization states disputes longstanding claims that cannabis is some sort of ‘gateway’ substance,” NORML Deputy Director Paul Armentano said in a blog post. “In fact, in many instances, cannabis regulation is associated with the decreased use of other substances, including many prescription medications.”

To that point, another recent study concluded that marijuana legalization is associated with decreased use of prescription drugs for the treatment of conditions such as anxiety, sleep, pain and seizures.

Several previous studies have identified associations with the enactment of medical cannabis legalization at the state level and reduced pharmaceutical prescriptions, but that paper focused on the potential impact of recreational legalization in 10 states plus Washington, D.C.

Last year, a study found that medical marijuana use is associated with significant reductions in dependence on opioids and other prescription drugs, as well as an increase in quality of life.

A meta-study that was published in 2020 also signaled that marijuana shows promise as a treatment option for chronic pain and could serve as an alternative to opioid-based painkillers.

Researchers released a study that year that found cannabis can mitigate symptoms of opioid withdrawal.

In 2019, researchers determined that states with legal marijuana access experience decreases in opioid prescriptions, and a separate study released the previous month showed that daily marijuana consumption is associated with reduced opioid consumption among chronic pain patients.

Delaware Governor Makes First Comments On Marijuana Legalization Bill Sent To His Desk

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page